Product image of Minirin (Desmopressin Acetate) supplied by GNH India

Minirin

Active Ingredient:
Desmopressin Acetate
Origin:
EU

Minirin (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Minirin, is a vasopressin analog presented as an oral tablet for oral use. It acts as an antidiuretic hormone to reduce excessive urine output in conditions such as central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders.

GNH India supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for bulk and small‑volume orders. All shipments are tracked and meet regulatory requirements for import and distribution.

Manufacturer / TM Owner

Ferring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin acetate is used to manage disorders of water balance and certain bleeding disorders.

  • Central diabetes insipidus: reduces excessive urine output and helps maintain normal plasma osmolality.
  • Nocturnal enuresis: lowers nighttime urine volume, supporting dry nights in children and adults.
  • Hemophilia A and von Willebrand disease: increases circulating factor VIII and von Willebrand factor, enhancing hemostasis during bleeding episodes.

How It Works

  • Desmopressin acetate is a synthetic analogue of vasopressin that selectively binds to V2 receptors on renal collecting‑duct cells. Receptor activation stimulates adenylate cyclase, raising intracellular cAMP and promoting insertion of aquaporin‑2 channels into the apical membrane, which increases water reabsorption. In endothelial cells it also triggers release of stored factor VIII and von Willebrand factor, improving clotting.

Side Effects

Desmopressin acetate may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

  • Headache: mild to moderate headache.
  • Nausea: occasional nausea or stomach discomfort.
  • Mild hyponatremia: slight reduction in serum sodium levels.
  • Flushing: transient facial flushing.

Serious or Rare Side Effects

  • Severe hyponatremia: can lead to seizures or coma.
  • Water intoxication: excessive fluid retention causing edema.
  • Allergic reaction: rash, itching, or anaphylaxis.

Precautions & Warnings

Before prescribing desmopressin, clinicians should consider several safety measures.

  • Assess renal function: evaluate kidney status before initiating therapy.
  • Monitor serum sodium: check electrolytes regularly, especially in elderly or water‑retaining conditions.
  • Limit fluid intake: advise patients to restrict excessive fluids to reduce hyponatremia risk.
  • Avoid concomitant hyponatremia‑inducing drugs: such as thiazide diuretics or carbamazepine.
  • Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited.
  • Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Avoid Interactions

Desmopressin can interact with several medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid)

  • Concomitant use of thiazide diuretics: may potentiate hyponatremia.
  • Carbamazepine or other enzyme‑inducing drugs: can reduce desmopressin effectiveness.
  • NSAIDs: may increase risk of water retention and hyponatremia.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (e.g., factor VIII concentrates): desmopressin may augment clotting factor levels, requiring dose adjustment.
  • Selective serotonin reuptake inhibitors (SSRIs): combined effect on water balance may increase hyponatremia risk.
  • Alcohol: can enhance antidiuretic effect, monitor fluid status.

Frequently Asked Questions

Minirin, containing desmopressin acetate, is prescribed for central diabetes insipidus to control excessive urination, for nocturnal enuresis to reduce nighttime bedwetting, and for certain bleeding disorders such as hemophilia A and von Willebrand disease to raise clotting factor levels.

Desmopressin acetate mimics the natural hormone vasopressin and selectively activates V2 receptors in the kidney collecting ducts. This triggers a cascade that increases cyclic AMP, causing aquaporin‑2 water channels to move to the cell surface, which enhances water reabsorption and concentrates urine. It also stimulates release of factor VIII and von Willebrand factor from endothelial cells.

The appropriate dose of Minirin is determined by a qualified prescriber based on the individual’s medical condition, age, renal function and response to therapy. Dosage may vary for each indication and should be adjusted according to clinical monitoring.

Safety data for desmopressin acetate in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a healthcare professional.

To request Minirin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Minirin (desmopressin acetate) is a synthetic vasopressin analog that selectively targets V2 receptors, offering a longer duration of action and fewer vasoconstrictive effects compared with natural vasopressin. Unlike some other antidiuretic drugs, it also has a hemostatic effect useful in certain bleeding disorders.

Minirin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure the container is tightly closed to maintain product stability.

Minirin is taken orally, usually as a tablet, with or without water as directed by the prescriber. The exact timing relative to meals or other medications depends on the indication and the clinician’s instructions.

The most serious risks include severe hyponatremia, which can lead to seizures, coma, or death, and water intoxication resulting in cerebral edema. Patients should be monitored closely for signs of low sodium and advised on fluid restriction when appropriate.

Minirin is contraindicated in individuals with known hypersensitivity to desmopressin acetate, uncontrolled hyponatremia, or conditions predisposing to water retention such as severe heart failure, uncontrolled diabetes mellitus, or chronic renal insufficiency. A healthcare professional should evaluate suitability before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desmopressin Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT